Ortho Kinematics, a privately held diagnostics company focused on spine imaging informatics, received Health Canada approval for its lead product, Vertebral Motion Analysis (VMA).
The VMA is a diagnostic test for the assessment of spinal motion and radiographic instability, and has been shown in peer-reviewed studies to be more accurate, repeatable and result in a lower dose of radiation, compared to the current standard test for assessing spinal radiographic instability. The VMA is currently available in the U.S. and Europe.
Ortho Kinematics plans to begin offering the VMA in Canada later this year, limiting initial distribution to a select group of spine centers.
In 3Q15, Ortho Kinematics announced the appointment of Tom Anderson as Vice President of Sales and Chris White as Vice President of Finance, to secure the management team required to support the company’s commercialization efforts.
Ortho Kinematics, a privately held diagnostics company focused on spine imaging informatics, received Health Canada approval for its lead product, Vertebral Motion Analysis (VMA).
The VMA is a diagnostic test for the assessment of spinal motion and radiographic instability, and has been shown in peer-reviewed studies to be more accurate,...
Ortho Kinematics, a privately held diagnostics company focused on spine imaging informatics, received Health Canada approval for its lead product, Vertebral Motion Analysis (VMA).
The VMA is a diagnostic test for the assessment of spinal motion and radiographic instability, and has been shown in peer-reviewed studies to be more accurate, repeatable and result in a lower dose of radiation, compared to the current standard test for assessing spinal radiographic instability. The VMA is currently available in the U.S. and Europe.
Ortho Kinematics plans to begin offering the VMA in Canada later this year, limiting initial distribution to a select group of spine centers.
In 3Q15, Ortho Kinematics announced the appointment of Tom Anderson as Vice President of Sales and Chris White as Vice President of Finance, to secure the management team required to support the company’s commercialization efforts.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
